NDC 0002-1220

TAUVID

Flortaucipir F-18

TAUVID is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Flortaucipir F-18.

• Product ID: 0002-1220_d03b2693-0231-4df4-a037-63017a42e85a
• NDC: 0002-1220
• Product Type: Human Prescription Drug
• Proprietary Name: TAUVID
• Generic Name: Flortaucipir F-18
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-07-01
• Marketing Category: NDA /
• Application Number: NDA212123
• Labeler Name: Eli Lilly and Company
• Substance Name: FLORTAUCIPIR F-18
• Active Ingredient Strength: 100 mCi/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0002-1220-48

1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-48) > 100 mL in 1 VIAL, MULTI-DOSE

• Marketing Start Date: 2022-07-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "TAUVID" or generic name "Flortaucipir F-18"

NDC	Brand Name	Generic Name
0002-1210	TAUVID	Flortaucipir F-18
0002-1220	TAUVID	Flortaucipir F-18